OKLAHOMA CITY, OK and IRVINE, CA -- (Marketwired) -- 08/06/13 --
Masimo (NASDAQ: MASI) today announced that OU Medical Center -- Oklahoma's only Level One trauma center for adults and pediatrics, and the state's largest and most comprehensive hospital -- has upgraded system-wide to MasimoSET® pulse oximetry, the standard-of-care at leading hospitals around the world.
OU Medical Center, the heart of a 776-bed system that includes The Children's Hospital at OU Medical Center, and OU Medical Center Edmond, joins a growing and distinguished roster of health organizations using Masimo SET® pulse oximetry, clinically shown to virtually eliminate false alarms1 and help clinicians detect life-threatening events.2 OU Medical Center's standardization to Masimo SET® pulse oximetry is in keeping with the healthcare organization's dedication to excellence in care and delivering the best possible results for its patients.
"Since we've been using Masimo pulse oximeters in the NICU, we've seen quite a difference," said Susan Bedwell, clinical nurse specialist, NICU, OU Medical Center. "We don't have as many motion-artifact alarms going off, where we used to have them going off all the time. And we're getting good low perfusion readings, even on our heart-lung bypass patients."
The performance of Masimo SET® pulse oximetry is proven by more than 100 independent and objective studies and thousands of clinical evaluations. Masimo SET® is trusted by clinicians to safely monitor more than 100 million patients each year and is used hospital-wide by eight of the top 10 hospitals on the U.S. News & World Report Best Hospitals Honor Roll (2013-2014). Compared to other pulse oximeters during patient motion and low perfusion, Masimo SET® provides measurements when other pulse oximeters cannot, dramatically reduces false alarms (specificity), and accurately detects true alarms (sensitivity)1 that can indicate a deteriorating patient. Most important, Masimo SET® pulse oximetry has been shown to improve patient outcomes by helping clinicians reduce retinopathy of prematurity (ROP)3 in neonates, screen newborns for critical congenital heart disease (CCHD),4,5 reduce ventilator weaning time and arterial blood gas measurements in the ICU,6 and save lives and costs while reducing rapid response activations and intensive care unit transfers on the general floor.7
"We are honored to partner with OU Medical Center, which has a well-deserved reputation for having patient empathy and providing quality care," said Masimo Founder and CEO Joe Kiani. "We also appreciate and share OU Medical Center's core values -- when it comes to doing what's right for patients, the word 'impossible' is not in our respective vocabularies. With this mutual commitment to excellence, we look forward to helping this great hospital and staff, meet and exceed their patient-care needs."
1 Shah N, Ragaswamy HB, Govindugari K, Estanol L "Performance of Three New-Generation Pulse Oximeters during Motion and Low Perfusion in Volunteers".J Clin Anesth. 2012 Aug;24(5):385-91.
2 Taenzer, Andreas H.; Pyke, Joshua B.; McGrath, Susan P.; Blike, George T. "Impact of Pulse Oximetry Surveillance on Rescue Events and Intensive Care Unit Transfers: A Before-and-After Concurrence Study." Anesthesiology, February 2010, Vol. 112, Issue 2. Available online here.
3 Castillo A, et al. Acta Paediatr. 2011 Feb.;100(2):188-92.
4 de-Wahl Granelli A., et al. BMJ. 2009 Jan 8;338.
5 Ewer A, et al. Health Technol Assess. 2012;16(2):1-184.
6 Durbin, et al. Critical Care Medicine. 2002 Aug.;30(8): 1735 to 1740.
7 Taenzer A, et al. Anesthesiology, 2010 Feb;112(2):282-7.
About OU Medical Center
OU Medical Center's dedication to patient care has remained strong for more than a century and we are positioned to grow even stronger in our second century. As part of OU Medicine, we are always working to provide for the health care of all Oklahomans and to solve medicine's toughest challenges. OU Medical Center, along with The Children's Hospital and OU Medical Center Edmond is Oklahoma's largest and most comprehensive hospital. The downtown campus is located in the heart of Oklahoma City, just minutes from downtown and the beautiful new Bricktown area and the State Capitol. We provide a full range of hospital services for every patient, from the smallest neonate to the most critically ill senior. Visit www.OUMedicine.com.
About Masimo
Masimo (NASDAQ: MASI) is the global leader in innovative noninvasive monitoring technologies that significantly improve patient care-helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through Motion and Low Perfusion pulse oximetry, known as Masimo SET®, which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. More than 100 independent and objective studies have shown that Masimo SET®outperforms other pulse oximetry technologies, even under the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced rainbow SET® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously required invasive procedures, including total hemoglobin (SpHb®), oxygen content (SpOCTM), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), and Pleth Variability Index (PVI®), in addition to SpO2, pulse rate, and perfusion index (PI). Additional information about Masimo and its products may be found at www.masimo.com.
Forward-Looking Statements
This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations about future events affecting us and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond our control and could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to: risks related to our assumptions that the hospital-wide conversion ensures that all OU Medical Center patients will be cared for using Masimo SET; risks related to our belief that Masimo SET provides real-time results for all patients to help clinicians to more rapidly assess, diagnose, and treat every patient; risks related to our assumptions regarding the repeatability of clinical results; as well as other factors discussed in the "Risk Factors" section of our most recent reports filed with the Securities and Exchange Commission ("SEC"), which may be obtained for free at the SEC's website at www.sec.gov. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarify these statements or the "Risk Factors" contained in our most recent reports filed with the SEC, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws.
Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care... by Taking Noninvasive Monitoring to New Sites and Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI, rainbow Acoustic Monitoring, RRa, Radical-7, Rad-87, Rad-57,Rad-8, Rad-5,Pulse CO-Oximetry, Pulse CO-Oximeter, Adaptive Threshold Alarm, and SEDLine are trademarks or registered trademarks of Masimo Corporation. The use of the trademarks Patient SafetyNet and PSN is under license from University HealthSystem Consortium.
Media Contacts:
Scott Coppenbarger
OU Medical Center
Phone: (405) 271-7900 x4
Email: scott.coppenbarger@hcahealthcare.com
Mike Drummond
Masimo Corporation
Phone: (949) 297-7434
Email: mdrummond@masimo.com
Source: Masimo